
According to a report from The Globe and Mail on November 14, Canadian anti-smoking advocates are urging the federal government to restrict the sale of the recently approved flavored nicotine product called "Zonnic" by the Ministry of Health. They have issued a warning stating that this product is being marketed and directly sold to children and adolescents.
Imperial Tobacco Canada, a subsidiary of British-American Tobacco, recently launched a nicotine pouch product called "Zonnic" in Canada. Each pouch contains four milligrams of nicotine and is designed to be placed under the user's lip.
However, anti-tobacco advocates are urging the federal government to restrict the sale of this product, or even suspend its sale altogether, in order to prevent underage individuals from purchasing it, given its increasing popularity and young user base in multiple countries, including the United States.
The open sale of Zonnic nicotine pouches in convenience stores and gas stations is causing concern about its impact on minors, despite being positioned by the company as an "adult tobacco alternative.
Anti-smoking groups, including the Canadian Cancer Society and the Canadian Doctors for Tobacco Control, are urging the government to take immediate action by implementing prescription-only sales for nicotine pouches. They are also calling for a suspension of approvals for similar products unless they too are subject to prescription-only sales.
British American Tobacco has identified nicotine pouches, which it refers to as "modern oral," as an important area for growth. During a meeting in September, Kingsley Wheaton, Chief Strategy and Growth Officer at British American Tobacco, expressed excitement about the future development of the company's modern oral products.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com